 Andrew Subudhi
Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude Sickness | 22 | 2025 | 150 | 4.540 |
Why?
| | Cerebrovascular Circulation | 23 | 2017 | 271 | 4.140 |
Why?
| | Acclimatization | 21 | 2025 | 172 | 3.480 |
Why?
| | Hypoxia | 31 | 2025 | 1165 | 3.470 |
Why?
| | Altitude | 31 | 2025 | 476 | 3.350 |
Why?
| | Oxygen Consumption | 21 | 2025 | 715 | 2.180 |
Why?
| | Exercise | 24 | 2025 | 2112 | 1.970 |
Why?
| | Oxygen | 20 | 2023 | 992 | 1.910 |
Why?
| | Middle Cerebral Artery | 7 | 2015 | 55 | 1.510 |
Why?
| | Homeostasis | 7 | 2017 | 636 | 1.500 |
Why?
| | Blood Flow Velocity | 13 | 2017 | 412 | 1.150 |
Why?
| | Hemoglobins | 5 | 2025 | 361 | 1.110 |
Why?
| | Epoetin Alfa | 1 | 2025 | 9 | 0.950 |
Why?
| | Erythropoietin | 1 | 2025 | 98 | 0.870 |
Why?
| | Iron | 1 | 2025 | 324 | 0.790 |
Why?
| | Brain | 8 | 2016 | 2868 | 0.780 |
Why?
| | Carbon Dioxide | 10 | 2015 | 241 | 0.720 |
Why?
| | Methazolamide | 1 | 2020 | 5 | 0.660 |
Why?
| | Theophylline | 1 | 2020 | 43 | 0.650 |
Why?
| | Arterial Pressure | 3 | 2016 | 131 | 0.650 |
Why?
| | Quadriceps Muscle | 4 | 2023 | 118 | 0.630 |
Why?
| | Muscle Fatigue | 6 | 2014 | 97 | 0.620 |
Why?
| | Antioxidants | 6 | 2013 | 599 | 0.610 |
Why?
| | Acute Disease | 9 | 2020 | 1010 | 0.540 |
Why?
| | Physical Endurance | 7 | 2020 | 275 | 0.540 |
Why?
| | Young Adult | 26 | 2025 | 13749 | 0.530 |
Why?
| | Posture | 2 | 2017 | 195 | 0.520 |
Why?
| | Bicycling | 10 | 2011 | 117 | 0.510 |
Why?
| | Adult | 46 | 2025 | 39391 | 0.480 |
Why?
| | Exercise Test | 8 | 2024 | 624 | 0.460 |
Why?
| | Cross-Over Studies | 8 | 2020 | 582 | 0.450 |
Why?
| | Muscle Contraction | 2 | 2007 | 435 | 0.430 |
Why?
| | Spectroscopy, Near-Infrared | 7 | 2020 | 66 | 0.410 |
Why?
| | Regional Blood Flow | 4 | 2013 | 498 | 0.400 |
Why?
| | Radial Artery | 2 | 2013 | 69 | 0.400 |
Why?
| | Male | 47 | 2025 | 70179 | 0.390 |
Why?
| | Ultrasonography, Doppler, Transcranial | 7 | 2013 | 44 | 0.390 |
Why?
| | Acetazolamide | 2 | 2011 | 26 | 0.370 |
Why?
| | Hypoxia, Brain | 2 | 2011 | 9 | 0.370 |
Why?
| | Athletic Performance | 2 | 2012 | 81 | 0.360 |
Why?
| | Oxidative Stress | 6 | 2018 | 1334 | 0.360 |
Why?
| | Humans | 65 | 2025 | 141749 | 0.340 |
Why?
| | Erythrocytes | 4 | 2017 | 707 | 0.340 |
Why?
| | Blood Pressure | 4 | 2017 | 1748 | 0.330 |
Why?
| | Hyperoxia | 2 | 2010 | 91 | 0.330 |
Why?
| | Atmospheric Pressure | 1 | 2010 | 26 | 0.320 |
Why?
| | Double-Blind Method | 9 | 2020 | 1989 | 0.320 |
Why?
| | Dexamethasone | 2 | 2011 | 380 | 0.310 |
Why?
| | Pulmonary Gas Exchange | 4 | 2019 | 117 | 0.300 |
Why?
| | Motor Cortex | 1 | 2009 | 63 | 0.290 |
Why?
| | Pulmonary Ventilation | 4 | 2013 | 83 | 0.290 |
Why?
| | Competitive Behavior | 1 | 2008 | 41 | 0.280 |
Why?
| | Physical Exertion | 2 | 2007 | 209 | 0.270 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 72 | 0.270 |
Why?
| | Muscle, Skeletal | 7 | 2023 | 1757 | 0.260 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 9 | 0.250 |
Why?
| | Exercise Tolerance | 2 | 2025 | 280 | 0.250 |
Why?
| | Frontal Lobe | 1 | 2007 | 163 | 0.250 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 65 | 0.250 |
Why?
| | Female | 27 | 2025 | 75943 | 0.250 |
Why?
| | Breathing Exercises | 1 | 2025 | 21 | 0.240 |
Why?
| | Respiratory Muscles | 1 | 2025 | 35 | 0.240 |
Why?
| | Prefrontal Cortex | 1 | 2009 | 316 | 0.240 |
Why?
| | Respiration | 5 | 2012 | 210 | 0.220 |
Why?
| | Ventricular Function, Right | 2 | 2024 | 283 | 0.220 |
Why?
| | Models, Cardiovascular | 3 | 2011 | 197 | 0.220 |
Why?
| | Adaptation, Physiological | 3 | 2016 | 562 | 0.210 |
Why?
| | Cerebral Cortex | 1 | 2007 | 462 | 0.200 |
Why?
| | Sports | 3 | 2012 | 219 | 0.200 |
Why?
| | Single-Blind Method | 5 | 2012 | 289 | 0.190 |
Why?
| | Blood Gas Analysis | 5 | 2015 | 82 | 0.190 |
Why?
| | Carotid Artery, Internal | 2 | 2012 | 44 | 0.190 |
Why?
| | Vertebral Artery | 2 | 2012 | 27 | 0.190 |
Why?
| | Anaerobic Threshold | 3 | 2009 | 28 | 0.180 |
Why?
| | Rest | 4 | 2015 | 128 | 0.180 |
Why?
| | Heart Rate | 5 | 2014 | 821 | 0.180 |
Why?
| | Skiing | 1 | 2001 | 51 | 0.160 |
Why?
| | Time Factors | 9 | 2016 | 6966 | 0.160 |
Why?
| | Proteomics | 2 | 2018 | 1138 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 253 | 0.140 |
Why?
| | Energy Metabolism | 3 | 2018 | 932 | 0.140 |
Why?
| | Metabolome | 2 | 2018 | 366 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 20 | 0.130 |
Why?
| | Inhalation | 2 | 2007 | 29 | 0.120 |
Why?
| | Sphingosine | 1 | 2016 | 45 | 0.120 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.120 |
Why?
| | Syncope | 1 | 2016 | 57 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2016 | 201 | 0.110 |
Why?
| | Foramen Ovale, Patent | 1 | 2015 | 10 | 0.110 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2016 | 199 | 0.110 |
Why?
| | Severity of Illness Index | 3 | 2013 | 2903 | 0.110 |
Why?
| | Tibet | 1 | 2014 | 24 | 0.110 |
Why?
| | Erythropoiesis | 1 | 2014 | 56 | 0.110 |
Why?
| | Bolivia | 1 | 2014 | 56 | 0.110 |
Why?
| | Peru | 1 | 2014 | 61 | 0.110 |
Why?
| | Glutathione | 3 | 2016 | 362 | 0.110 |
Why?
| | Mountaineering | 2 | 2011 | 41 | 0.100 |
Why?
| | Lipid Peroxidation | 2 | 2004 | 150 | 0.100 |
Why?
| | Carotid Artery, External | 1 | 2012 | 3 | 0.090 |
Why?
| | Healthy Volunteers | 3 | 2018 | 215 | 0.090 |
Why?
| | Surveys and Questionnaires | 5 | 2013 | 5974 | 0.090 |
Why?
| | Analysis of Variance | 4 | 2010 | 1321 | 0.090 |
Why?
| | Malondialdehyde | 2 | 2009 | 29 | 0.090 |
Why?
| | Pulse Wave Analysis | 1 | 2012 | 237 | 0.090 |
Why?
| | Motor Activity | 2 | 2014 | 720 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1942 | 0.090 |
Why?
| | Blood Proteins | 1 | 2013 | 250 | 0.090 |
Why?
| | Skull | 1 | 2012 | 151 | 0.090 |
Why?
| | Pulmonary Edema | 2 | 2010 | 114 | 0.090 |
Why?
| | Vasoconstriction | 1 | 2012 | 219 | 0.090 |
Why?
| | Body Temperature Regulation | 1 | 2012 | 102 | 0.090 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 82 | 0.090 |
Why?
| | Glycolysis | 3 | 2018 | 327 | 0.080 |
Why?
| | Cold Temperature | 1 | 2012 | 196 | 0.080 |
Why?
| | Lactic Acid | 3 | 2009 | 303 | 0.080 |
Why?
| | Cerebral Arteries | 1 | 2011 | 59 | 0.080 |
Why?
| | Forecasting | 1 | 2012 | 384 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2018 | 1087 | 0.080 |
Why?
| | Running | 1 | 2012 | 232 | 0.080 |
Why?
| | Fourier Analysis | 1 | 2009 | 40 | 0.080 |
Why?
| | Ribose | 1 | 2009 | 22 | 0.080 |
Why?
| | Manometry | 1 | 2009 | 97 | 0.080 |
Why?
| | Vasodilation | 1 | 2012 | 516 | 0.080 |
Why?
| | Hot Temperature | 1 | 2012 | 406 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2012 | 368 | 0.080 |
Why?
| | Reaction Time | 1 | 2011 | 432 | 0.070 |
Why?
| | Anticonvulsants | 1 | 2011 | 226 | 0.070 |
Why?
| | Heart Ventricles | 2 | 2024 | 753 | 0.070 |
Why?
| | Algorithms | 3 | 2014 | 1768 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1774 | 0.070 |
Why?
| | Exhalation | 1 | 2007 | 29 | 0.070 |
Why?
| | Pentose Phosphate Pathway | 2 | 2018 | 53 | 0.070 |
Why?
| | Oxyhemoglobins | 1 | 2007 | 24 | 0.070 |
Why?
| | Nutritional Requirements | 1 | 2007 | 81 | 0.060 |
Why?
| | Blood Volume | 1 | 2007 | 65 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 47 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 78 | 0.060 |
Why?
| | Sports Medicine | 1 | 2008 | 117 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2075 | 0.060 |
Why?
| | Drinking | 1 | 2005 | 42 | 0.060 |
Why?
| | Cognition | 1 | 2014 | 1228 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 595 | 0.060 |
Why?
| | Recovery of Function | 1 | 2009 | 684 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2007 | 168 | 0.060 |
Why?
| | Physical Education and Training | 1 | 2004 | 74 | 0.050 |
Why?
| | Placebos | 1 | 2004 | 198 | 0.050 |
Why?
| | Reproducibility of Results | 3 | 2007 | 3356 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4136 | 0.050 |
Why?
| | Pilot Projects | 2 | 2025 | 1826 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2006 | 424 | 0.050 |
Why?
| | Partial Pressure | 2 | 2013 | 31 | 0.050 |
Why?
| | Hypercapnia | 2 | 2013 | 54 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2004 | 560 | 0.050 |
Why?
| | DNA Damage | 1 | 2004 | 429 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2014 | 2096 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2006 | 792 | 0.040 |
Why?
| | Adolescent | 3 | 2017 | 22130 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5909 | 0.040 |
Why?
| | Chronic Disease | 1 | 2007 | 1820 | 0.040 |
Why?
| | Colorimetry | 1 | 2001 | 12 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2011 | 14 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1250 | 0.040 |
Why?
| | Brain Edema | 2 | 2011 | 64 | 0.040 |
Why?
| | Bone Density | 1 | 2004 | 495 | 0.040 |
Why?
| | Tidal Volume | 2 | 2012 | 102 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2902 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 3071 | 0.040 |
Why?
| | Dehydration | 2 | 2012 | 54 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2011 | 11181 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Carnitine | 1 | 2018 | 83 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 175 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 367 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Muscles | 1 | 2018 | 333 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 16 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 107 | 0.030 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 120 | 0.030 |
Why?
| | Diet | 1 | 2004 | 1282 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 46 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 240 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 61 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 129 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 309 | 0.030 |
Why?
| | Animals | 5 | 2017 | 37748 | 0.030 |
Why?
| | Purines | 1 | 2016 | 182 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2015 | 60 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 260 | 0.030 |
Why?
| | Biomarkers | 3 | 2013 | 4190 | 0.030 |
Why?
| | Proteins | 1 | 2001 | 1015 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 450 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 811 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 454 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 497 | 0.030 |
Why?
| | Heart Sounds | 1 | 2014 | 2 | 0.030 |
Why?
| | Heart Auscultation | 1 | 2014 | 3 | 0.030 |
Why?
| | Acid-Base Equilibrium | 1 | 2013 | 24 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 464 | 0.030 |
Why?
| | Chemoreceptor Cells | 1 | 2013 | 53 | 0.030 |
Why?
| | Markov Chains | 1 | 2014 | 126 | 0.030 |
Why?
| | Enzymes | 1 | 2013 | 65 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 151 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 304 | 0.020 |
Why?
| | Cold Climate | 1 | 2012 | 7 | 0.020 |
Why?
| | Validation Studies as Topic | 1 | 2012 | 22 | 0.020 |
Why?
| | Hypocapnia | 1 | 2012 | 8 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2014 | 303 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 556 | 0.020 |
Why?
| | Risk Factors | 3 | 2012 | 10482 | 0.020 |
Why?
| | Frostbite | 1 | 2012 | 23 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2013 | 3597 | 0.020 |
Why?
| | Hypothermia | 1 | 2012 | 45 | 0.020 |
Why?
| | Respiration Disorders | 1 | 2012 | 79 | 0.020 |
Why?
| | Health Facilities | 1 | 2012 | 85 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 703 | 0.020 |
Why?
| | Heat Stress Disorders | 1 | 2012 | 82 | 0.020 |
Why?
| | Blood Circulation Time | 1 | 2010 | 3 | 0.020 |
Why?
| | Constriction | 1 | 2010 | 47 | 0.020 |
Why?
| | Vasomotor System | 1 | 2010 | 47 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 568 | 0.020 |
Why?
| | Headache | 1 | 2011 | 153 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 145 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 618 | 0.020 |
Why?
| | Mice | 2 | 2017 | 18108 | 0.020 |
Why?
| | Pulse | 1 | 2009 | 26 | 0.020 |
Why?
| | Free Radicals | 1 | 2009 | 114 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1977 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 2009 | 61 | 0.020 |
Why?
| | Software | 1 | 2014 | 678 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 153 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2010 | 184 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 177 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 482 | 0.020 |
Why?
| | Epinephrine | 1 | 2008 | 148 | 0.020 |
Why?
| | Norepinephrine | 1 | 2008 | 193 | 0.020 |
Why?
| | Self Disclosure | 1 | 2007 | 65 | 0.020 |
Why?
| | Magnetics | 1 | 2007 | 48 | 0.020 |
Why?
| | Lactates | 1 | 2007 | 85 | 0.020 |
Why?
| | Dogs | 1 | 2008 | 427 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 93 | 0.010 |
Why?
| | Urinalysis | 1 | 2005 | 77 | 0.010 |
Why?
| | Sleep | 1 | 2012 | 885 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 2004 | 10 | 0.010 |
Why?
| | Maximal Expiratory Flow Rate | 1 | 2004 | 2 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2009 | 570 | 0.010 |
Why?
| | Oximetry | 1 | 2005 | 127 | 0.010 |
Why?
| | Models, Biological | 1 | 2012 | 1828 | 0.010 |
Why?
| | Middle Aged | 2 | 2020 | 34647 | 0.010 |
Why?
| | Electromyography | 1 | 2007 | 411 | 0.010 |
Why?
| | Anthropometry | 1 | 2004 | 208 | 0.010 |
Why?
| | Equipment Design | 1 | 2005 | 525 | 0.010 |
Why?
| | Task Performance and Analysis | 1 | 2004 | 197 | 0.010 |
Why?
| | Signal Transduction | 1 | 2017 | 5168 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 803 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 858 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 513 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2004 | 273 | 0.010 |
Why?
| | Body Weight | 1 | 2005 | 997 | 0.010 |
Why?
| | Data Collection | 1 | 2004 | 662 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2799 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1406 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4421 | 0.010 |
Why?
| | Child | 1 | 2014 | 22414 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7777 | 0.010 |
Why?
| | United States | 1 | 2004 | 15310 | 0.000 |
Why?
|
|
Subudhi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|